Immutep Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Apr 19, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Apr 19, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, corporate-update, foreign-private-issuer
TL;DR
Immutep (IMPP) filed a 6-K, standard update. Nothing major.
AI Summary
Immutep Limited filed a Form 6-K on April 19, 2024, reporting information as of April 18, 2024. The company, previously known as Prima BioMed Ltd, is incorporated in Australia and its fiscal year ends on June 30. Its principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Why It Matters
This filing provides an update on Immutep's corporate information and regulatory status with the SEC, which is important for investors tracking the company's compliance and official disclosures.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure (Form 6-K) and does not appear to contain significant new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- IMMUTEP Ltd (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- April 18, 2024 (date) — Date of report
- April 19, 2024 (date) — Filing date
- Level 32, Australia Square 264 George Street, Sydney NSW 2000, Australia (location) — Principal executive office address
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public pursuant to the laws of their home country, or that they have filed or are required to file with a stock exchange.
When was Immutep Limited previously known as?
Immutep Limited was previously known as Prima BioMed Ltd, with a date of name change on November 19, 2010.
What is Immutep's fiscal year end?
Immutep's fiscal year ends on June 30.
What is the SEC file number for Immutep Limited?
The SEC file number for Immutep Limited is 001-35428.
Does Immutep file its annual reports under Form 20-F or 40-F?
Immutep files its annual reports under cover of Form 20-F.
Filing Stats: 259 words · 1 min read · ~1 pages · Grade level 17 · Accepted 2024-04-18 18:57:26
Filing Documents
- d830354d6k.htm (6-K) — 9KB
- d830354dex991.htm (EX-99.1) — 13KB
- g830354dsp0004.jpg (GRAPHIC) — 9KB
- 0001193125-24-101096.txt ( ) — 37KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: April 18, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer